EDGAR Filing Documents for 9999999995-21-003572

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-21-003572

Accepted

2021-09-20 00:15:22

Documents

Effectiveness Date

2021-09-17

Registration Form

S-3

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	603
	Complete submission text file	9999999995-21-003572.txt		2003

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010

Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200

Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)